,Date,Study,Study Link,Journal,Tool,Result,Study Type,Measure of Evidence Strength,Sample (n)
0,2020-05-31,Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection.,https://doi.org/10.1016/j.jinf.2020.02.029,Journal of Infection,,85% of patients critically ill showed lymphopenia (800 cells/ml median),,,Unknown
1,2020-04-17,Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series,https://doi.org/10.1101/2020.04.14.20059733,medrxiv,Flow cytometry/peptide microarray,"Severe illness correlated with delayed, but broad SARS-CoV-2-specific IgA response",,,5
2,2020-04-17,Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells,https://doi.org/10.1101/2020.04.16.045617,bioxriv,Single Cell RNA analysis/transcriptome analysis,ACE2-positive AT2 cells co-express pathogen receptors (e.g. DMBT1),,,19
3,2020-04-07,The phenotypic changes of γδ T cells in COVID-19 patients,https://doi.org/10.1101/2020.04.05.20046433,medrxiv,Flow Cytometry,Disproportionate increase in γδ CD4 T cells in COVID-19 patients,,,56
4,2020-03-15,Zoonotic origins of human coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098031/,Int J Biol Sci,,ORF8 Accessory protein mutations drive viral phenotypes,Prospective Cohort,,Unknown
5,2020-03-06,The potential role of IL-6 in monitoring severe case of coronavirus disease 2019,https://doi.org/10.1101/2020.03.01.20029769,medrxiv,Peripheral Blood Test,Elevated IL-6 associated with disease severity and progression,Prospective Cohort,,69
